Rhumbline Advisers Raises Stake in AdaptHealth Corp. (NASDAQ:AHCO)

Rhumbline Advisers boosted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 0.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 313,110 shares of the company’s stock after purchasing an additional 1,691 shares during the period. Rhumbline Advisers owned approximately 0.23% of AdaptHealth worth $2,981,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. grew its position in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the period. Quarry LP boosted its position in AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after purchasing an additional 5,838 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares during the period. CIBC Asset Management Inc purchased a new stake in shares of AdaptHealth in the third quarter valued at approximately $122,000. Finally, LRI Investments LLC raised its stake in shares of AdaptHealth by 32.0% during the 3rd quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock worth $172,000 after buying an additional 3,713 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AHCO has been the subject of several recent analyst reports. Robert W. Baird boosted their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday. UBS Group cut their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Truist Financial raised their price target on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday. Royal Bank of Canada boosted their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Canaccord Genuity Group raised their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $13.80.

AdaptHealth Stock Up 2.6 %

Shares of NASDAQ AHCO opened at $11.38 on Friday. The business has a 50-day moving average of $9.92 and a two-hundred day moving average of $10.23. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of -6.90, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. AdaptHealth Corp. has a 1 year low of $8.35 and a 1 year high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.